Synthesis and Antiplatelet Adhesion Behavior of a Poly(L-lactide--glycolide)-Poly(1,5-dioxepan-2-one) Multiblock Copolymer.

ACS Omega

Department of General Internal Medicine and Clinical Laboratory Medicine, Graduate School of Medicine, Akita University, 1-1-1, Hondo, Akita-shi, Akita 010-8543, Japan.

Published: October 2021

Platelet adhesion and denaturation on artificial medical implants induce thrombus formation. In this study, bioabsorbable copolymers composed of poly(l-lactide--glycolide) (PLGA) and poly(1,5-dioxepan-2-one) (PDXO) were synthesized and evaluated for their antiplatelet adhesive properties. The PLGA-PXO multiblock copolymer (PLGA-PDXO MBC) and its random copolymer (PLGA-PDXO RC) showed effective antiplatelet adhesive properties, and the number of adhered platelets was similar to those adhered on poly(2-methoxyethylacrylate), a known antiplatelet adhesive polymer, although a large number of denatured platelets were observed on a PLGA-poly(ε-caprolactone) multiblock copolymer (PLGA-PCL MBC). Using monoclonal antifibrinogen IgG antibodies, we also found that both αC and γ-chains, the binding sites of fibrinogen for platelets, were less exposed on the PLGA-PDXO MBC surface compared to PLGA-PCL MBC. Furthermore, free-standing films of PLGA-PDXO MBC were prepared by casting the polymer solution on glass plates and showed good tensile properties and slow hydrolytic degradation in phosphate-buffered saline (pH = 7.4). We expect that the unique properties of PLGA-PDXO MBC, i.e., antiplatelet adhesive behavior, good tensile strength, and hydrolytic degradation, will pave the way for the development of new bioabsorbable implanting materials suitable for application at blood-contacting sites.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552321PMC
http://dx.doi.org/10.1021/acsomega.1c03846DOI Listing

Publication Analysis

Top Keywords

antiplatelet adhesive
16
plga-pdxo mbc
16
multiblock copolymer
12
adhesive properties
8
copolymer plga-pdxo
8
plga-pcl mbc
8
good tensile
8
hydrolytic degradation
8
mbc
6
plga-pdxo
5

Similar Publications

A New Shear-Stress-Based Point-of-Care Technology for Evaluation of the Hemostatic Pattern in Whole Blood.

Biosensors (Basel)

October 2024

Stem Cell Unit, Department of Research and Advanced Cancer Diagnostic, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.

The currently available point-of-care hemostasis tests are burdened by criticisms concerning the use of different activators and inhibitors and the lack of dynamic flow. These operating conditions may constitute an impediment to the determination of the patient's hemostatic condition. Hence, the diffusion of these tests in clinical practice is still limited to specific scenarios.

View Article and Find Full Text PDF

The Role of Platelets in Atherosclerosis: A Historical Review.

Semin Thromb Hemost

November 2024

Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Atherosclerosis is a chronic, multifactorial inflammatory disorder of large and medium-size arteries, which is the leading cause of cardiovascular mortality and morbidity worldwide. Although platelets in cardiovascular disease have mainly been studied for their crucial role in the thrombotic event triggered by atherosclerotic plaque rupture, over the last two decades it has become clear that platelets participate also in the development of atherosclerosis, owing to their ability to interact with the damaged arterial wall and with leukocytes. Platelets participate in all phases of atherogenesis, from the initial functional damage to endothelial cells to plaque unstabilization.

View Article and Find Full Text PDF
Article Synopsis
  • This study analyzes how different platelet collagen receptors (GPVI, α2β1, and GPIb-IX-V) interact with various sources of collagen, impacting platelet activation and thrombus formation.
  • Ethical collagens tested include type I collagen from equine tendon, rat tail, and acid-soluble collagen from human umbilical cord.
  • The results show varied reliance on receptors for platelet aggregation depending on the collagen type, with GPVI playing a crucial role in reducing thrombus parameters when inhibited, demonstrating that collective receptor interactions influence platelet behavior on different collagen surfaces.
View Article and Find Full Text PDF
Article Synopsis
  • Infections and thrombosis pose challenges for implanted cardiovascular devices, highlighting the need for improved surfaces with better blood compatibility and antimicrobial features.
  • This study introduces a novel method to create multifunctional surfaces for left ventricular assist devices (LVADs) by integrating nitric oxide generation catalysts, heparin, and silver nanoparticles.
  • The results show successful immobilization of these components, leading to reduced platelet adhesion, good hemocompatibility, and effective antimicrobial properties without hindering cell growth, suggesting potential for clinical applications in LVADs.
View Article and Find Full Text PDF
Article Synopsis
  • Medical devices that contact blood can cause clotting and other complications, which is typically managed using anticoagulants and antiplatelet agents, though these can increase bleeding risks.
  • A new method investigates coating polydimethylsiloxane (PDMS) surfaces with an antithrombin-heparin complex and tissue plasminogen activator to inhibit clotting and dissolve early clots.
  • Different coating processes were tested, and the results showed that a specific sequential application of these agents improved their effectiveness and stability, suggesting potential for better blood compatibility in medical devices.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!